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Background: To assess postoperative rhinological complaints, length of hospital stay and complications
related to endoscopic, endonasal trans-sphenoidal procedures.
Patients and methods: From May 2001 through May 2007, a retrospective analysis was conducted on a
series of 39 patients that underwent endonasal surgery and 9 patients that had craniotomy removal of
pituitary tumors. Questionnaires were ﬁlled out at both 2 weeks and 3 months after surgery, most of
which were completed in the outpatient department if the patient was discharged. Nasal packing lasted
for 72 h in 29 patients, but not in the last 10 patients.
Results: Of the 12 patients with preoperative headache, 50% had complete resolution, 33% had partial
resolution and 17% reported no change. The frequency of rhinological complaints declined between the
two questionnaires (p < .001). After 3 months, 64e84% of patients had no rhinological complaints, while
2.5% had severe complaints. Of the 9 patients with complications, rhinological complaint severity was
similar to those without complications (p < .001).
Conclusions: The direct endonasal trans-sphenoidal approach for pituitary fossa tumor is associated with
a rapid rhinological recovery, shorter hospital stay and a low occurrence of serious long-term sinonasal
complaints.
Copyright © 2016, The Chinese Oncology Society. Production and hosting by Elsevier B.V. This is an open
access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
The ﬁrst transcranial operation on a pituitary adenoma was
performed by Victor Horsley in 1904; 3 years later, the ﬁrst trans-
sphenoidal operation was performed by Hermann Schloffer.1,2 A
direct endonasal approach to the sella, requiring removal of the
middle turbinate and part of the nasal septum, was ﬁrst described
by Hirsch in 1910.1,2 In 1912, Cushing introduced the sublabial
trans-sphenoidal approach, which Dott, Guiot,3 and Hardy4,5
repopularized in the 1950s and 60s.1,2 Although the sublabial
approach has been the favored surgical route to the sella for manyTaipei Medical University e
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Society. Production and hosting byyears, an endonasal approach with the operating microscope, and
more recently with the endoscope alone or an endoscope-assisted
approach, has gained popularity, both for neurosurgeons and their
patients.6e10
The endonasal approach, currently used by many pituitary
surgeons, was ﬁrst described by Grifﬁth in 1987 as a reﬁnement of
Hirsch's original approach.11 Instead of three mucosal tunnels, as in
the sublabial route, or one mucosal tunnel, as utilized in the
transseptal approach, the direct endonasal approach requires no
mucosal tunnels and only one mucosal incision in the posterior
nasal cavity12 (Fig. 1) (Fig. 2). We have been using the direct
endonasal approach for all pituitary tumors for many years. This
report documents our experiences with 39 patients who under-
went endonasal resection of a pituitary adenoma or other sellar
lesions and 9 patients who received craniotomy removal of a pi-
tuitary tumor.Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://
Fig. 1. Right: Illustrations showing Hardy's sublabial trans-septal trans-sphenoidal approach. A: Sublabial incision. B: Elevation of nasal mucosa from the ﬂoor. C: Submucosal
dissection from the septum. D: Resection of the cartilaginous septum with a swiveled knife. E: Sagittal view of the submucosal dissection. F: Introduction of the self-retaining
speculum that reveals the vomer, which resembles the keel of a ship. G: Sagittal view of the speculum in position. Upper Right: Operative drawing showing the sella turcica
portion of the procedure. A: Resection of the vomer and the ﬂoor of the sphenoid sinus, exposing the sella turcica. B: Opening of the sellar ﬂoor with a rongeur. C: Cruciate incision
made in the dura of the sella turcica. D: Horizontal view of the strict midline approach to the sella turcica. Lower Right: Drawing showing selective removal of a pituitary
microadenoma while preserving pituitary function. (Reprinted with permission from Hardy J: J Neurosurg 34:582e594, 1971.)
Fig. 2. Drawings showing an endonasal endoscopic approach to the sella turcica. A: Note the absence of septal or alar incisions. B: The endoscope is held in the surgeon's
nondominant hand and instruments are held in the dominant hand until the anterior sphenoidotomy is made. (Reprinted from Surg Neurol 47, Jho HD, et al: Endoscopic pituitary
surgery: an early experience, 1997, with permission from Elsevier Science.).
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2.1. Patient population
Thirty-nine patients who underwent endonasal surgery for a
pituitary adenoma or other parasellar tumors and 9 patients who
received craniotomy removal of a pituitary tumor, at the Depart-
ment of Neurosurgery, Mackay Memorial Hospital, between May
2001 andMay 2007, were eligible for this study. Patient charts werereviewed for demographics, length of stay and surgical
complications.
2.2. Questionnaire
Questionnaires were ﬁlled out at 2 weeks and 3 months after
surgery; most were ﬁlled out in the outpatient department, if the
patient was discharged. Patients were asked questions related to
headaches and to 4 areas related to rhinological recovery,
Table 1
Pathological diagnoses in 39 patients.
Pathology No. of patients
Pituitary adenoma 37
Endocrine-inactive 22
Prolactinoma 7
Cushing's disease 4
Acromegaly 4
TSH secreting 0
Rathke's cleft cyst 2
Total 39
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olfaction.
2.3. Surgical technique
We performed endonasal surgery as it was originally described
by Grifﬁth and Veerapen,11 with several modiﬁcations described in
this section. Following general anesthesia, patients were placed in
the supine, semi-slouch position, with the head resting freely on
the bed and angled approximately 30 toward the left shoulder, as
described by Laws.13 A few key points regarding rhinological as-
pects of the approach warrant emphasis. First, initial preparation of
each nasal cavity involved only a brief swabbing with betadine-
soaked, cotton-tipped applicators; and injection of vasoconstric-
tors. Second, during the initial approach, care was taken to mini-
mize mucosal trauma and bleeding from the hand-held speculum
and insertion of the modiﬁed Hardy speculum. Third, the only
mucosal incision deliberately made was at the junction of the
posterior nasal septum and sphenoid keel. Fourth, entering the
sphenoid sinus, the only mucosa typically removed was that lining
the anterior sphenoid sinus wall and overlying the sella. Fifth, upon
procedure completion, after removing the modiﬁed Hardy specu-
lum, the hand-held speculum was again used to explore both the
operated and nonoperated nasal cavities to identify signiﬁcant
mucosal bleeding, which was stopped with the bipolar, Gelfoam or
Surgifoam. Sixth, the middle turbinate on the side of the approach,
which was out-fractured by the speculum at the start of the pro-
cedure, was repositioned by medializing it toward the nasal
septum.
Twenty-nine (74%) patients had abdominal fat grafts and nasal
packing placed for 72 h to prevent CSF leak and prevent hemor-
rhage. In the subsequent 10 patients, nasal packing and abdominal
fat graft were not used. During the ﬁrst postoperative night, pa-
tients were given a humidiﬁed face tent and decongestants were
available upon request. Antibiotics were given for a period of 72 h
after surgery.
Analysis included demographics, length of stay, complication
rates, rhinological complaints, preoperative headaches, visual
functioning and endocrinological outcomes with any noted com-
plications. We also included subgroup analyses of patients with
nasal packing as compared to its absence, complications as
compared to their absence and comparison of craniotomy
approaches.
2.4. Statistical analysis
Numerical data (e.g. hospital duration) were analyzed through
ANOVA. Differences between groups (craniotomy vs endonasal
techniques, etc.) were tested by Chi-squared and Fisher's exact test.
3. Results
3.1. Demographics
In this study, the 39 endonasal trans-sphenoidal patients ranged
in ages from 21 to 72 years, and 23 (59%) were female. Furthermore,
pathology included 37 (94%) pituitary adenomas and 2 (5%)
Rathke's cleft cysts (Table 1).
3.2. Length of stay and complication rate
Themedian length of staywas 12 days (range: 4e48), withmore
than 48% of patients going home by day 7 (Fig. 3). Nine (23%) pa-
tients had surgical complications, the most common of which were
anterior hypopituitarism of one or more hormonal axis (7%),postoperative CSF leak (5%) and persistent diabetes insipidus (2%).
In addition, there was 1 patient with transient postoperative
meningitis. In the entire cohort, there was 1 carotid artery injury
(without neurological sequela) and non-postoperative sellar he-
matoma. There were no permanent ocular palsies or visual wors-
ening. However, there was one mortality. Of the 39 patients, 30 had
non-surgical complications (Table 2).
3.3. Questionnaire results
Postoperative complaint frequency, including headache, nasal
congestion, decreased airﬂow and decreased olfaction, declined
signiﬁcantly in the period between the two questionnaires
(p < .001) (Fig. 4).
3.4. Preoperative headache
Of the 12 patients with preoperative headaches, 6 had complete
resolution, 3 had partial resolution and 3 reported no change.
3.5. Visual function and other cranial nerve palsies
Of the 22 patients with preoperative visual defects, 16 (72%) had
improved vision and 6 (27%) had no change. No patients experi-
enced postoperative worsening of visual acuity or visual ﬁelds, or
new cranial nerve palsies.
3.6. Endocrinological outcomes
Four patients (10%) had endocrinological complications, all of
whom had harbored macroadenomas. Three patients lost anterior
pituitary functioning of the thyroid axis and required long-term
thyroxin support. One patient developed permanent diabetes
insipidus (DI) and required long-term Desmopressin (minirin
0.1 mg twice daily) (Table 3). Transient DI was observed in 10% of
patients and it typically resolvedwithin 3 days of surgery. Transient
delayed hyponatremia was observed in 1 patient.
3.7. Surgical and medical complications
There was one mortality, a 46-year-old patient with an
endocrine-inactive macroadenoma and a history of arrhythmia and
atrial ﬁbrillation. He suffered from post-operative DI. Fluid support,
desmopressin and vasopressinwere used. However, sudden cardiac
arrest occurred the night following the operation, which cardio-
pulmonary resuscitation failed to prevent.
There was onemajor surgical complication, a carotid injury. This
occurred in a 56-year-old man with a 2-cm-wide GH-secreting
adenoma. He suffered an inadvertent puncture injury to the left
internal carotid artery, which was packed with Gelfoam and fat
graft. Twenty days after surgery, there was right eye pain and
swelling. A carotid-cavernous ﬁstula was identiﬁed on follow-up
Fig. 3. Hospital stay for all 39 patients. Overall, 48% of patients were discharged by postoperative day 7.
Table 2
Complications of endonasal trans-sphenoidal surgery.
Complication No. of patients
Persistent DI 1
CSF leak 2
Loss of anterior pituitary axis 3
Meningitis 1
Carotid injury 1
Death 1
None 30 (77%)
Fig. 4. Postoperative headache, nasal congestion, decreased airﬂow and decreased
olfaction, declined signiﬁcantly from 2 weeks after surgery to 3 monthsþ (p < .001).
Table 3
Endocrinological outcomes: hormonal losses.
Change in hormonal axis No. of patients
Anterior gland
Lost thyroid axis 3
Lost cortisol axis 0
Lost GH axis 0
Posterior gland
Permanent DI 1
No change in axes 35
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endovascular placement of Guglielmi coils. The patient recovered
without any detectable visual deﬁcits.
Postoperative CSF leak occurred in 2 patients; both had intra-
operative abdominal fat graft impact. Lumbar CSF drainage was
used, after which both patients also suffered from meningitis,
which resolved completely in response to a 6-week course of an-
tibiotics. There was no post-lumbar drainage at 7 and 10 days. Both
patients made a full recovery, without sequelae.4. Subgroup analyses
4.1. Nasal packing VS no nasal packing
Regarding the in-hospital postoperative period, more than 82%
of patients with packing complained about the packing and/or
mouth breathing. At 2 weeks after surgery, patients with packing
complained of nasal congestion and decreased nasal airﬂow (75%
and 68%), compared with 3months after surgery (37% and 30%) and
also compared with those without packing (31% and 20%). By 3
months, this difference was lost (p-values all >.1).4.2. Comparison with craniotomy
Nine patients were in the craniotomy group (Table 4). In this
group, the pituitary tumor size for all patients was large, at 3 cm in
diameter, and presented a difﬁcult approach using the trans-
sphenoidal method. Seven patients had pituitary macroadenoma,
one patient had pituitary metastatic neuroblastoma and one had
pituitary malignant lymphoma. The craniotomy group median
hospital stay was 36.6 days, as compared to 12 days for the endo-
nasal group. The craniotomy group had high rates of new post-
operative headaches (44%) and post-operative pneumonia (44%),
as opposed to 15 and 0% in the endonasal group (p < .001 for all).Table 4
Pituitary tumor in craniotomy group 9 patients.
Age F/M Pathological
32 M Pituitary macroadenoma
56 M Pituitary macroadenoma
11 M Metastatic neuroblastoma
34 M Pituitary macroadenoma
68 F Pituitary macroadenoma
65 M Pituitary malignant lymphoma
67 F Pituitary macroadenoma
65 F Pituitary macroadenoma
72 M Pituitary macroadenoma
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Median hospital length of stay for 9 patients who had surgical or
other postoperative complicationwas 22.9 days (range, 6e48 days)
compared to the “without complication” group median hospital
length of stay of 6.7 days (range, 4e12 days). Postoperative head-
ache and rhinological complaints at 3 months, rates of new head-
ache (22%), nasal congestion (33%) and nasal airﬂow decrease (33%)
were similar to patients without complications; however, more
patients complained of decreased olfaction (55%) (p < .001).
Differential diagnosis of malignant diseases arising within the
clivus of the adjacent structures of the pituitary fossa.
The main important malignant diseases of the clivus were
chordoma, chondrosarcoma, ﬁbrous dysplasia, myeloma, and
metastasis arising within the clivus. In clinical presentations of the
clivus tumor, patients were noted to be often with cranial nerve
palsies or headache.14,15 Diplopia results from involvement of the
abducens nerve in Dorello's canal on the posterior surface of the
clivus.15,16 Endocrinopathy may occur depending on inﬁltration of
the pituitary.
4.4. Chordoma
Chordoma is typically a slow-growing and histologically low
grade neoplasm, which is locally invasive and has a high recurrence
rate, with a clinical progression similar to malignant tumors. The
average 5-year progression-free survival and overall survival are
51% and 78%, respectively.17
4.5. Chondrosarcomas
Chondrosarcomas account for 6% of skull-base tumors.18 They
develop from primitive mesenchymal cells19 in synchondroses of
the skull base with a high predilection for the petroclival syn-
chondrosis20; therefore, they develop in a paramedian location.18
Differentiating chondrosarcomas from chordomas is important as
the 5-year progression-free survival is >90% for chondrosarcoma
compared to around 51% for chordoma.21
4.6. Metastasis
Metastasis appears to be less likely than chordoma or chon-
drosarcoma.16 The most common primary sites for metastasis were
prostate, thyroid, and hepatocellular carcinomas, with the prostatic
origin conferring a male predominance.16 Patients with metastases
had a poor prognosis of approximately 10 months survival.16
4.7. Plasmacytomas/myeloma
Extramedullary plasmacytomas, bone plasmacytomas and
multiple myeloma are monoclonal plasma cell proliferations.
Multiple myeloma is considered to be the malignant diffuse ﬁnal
stage.22
5. Discussion
This study demonstrates that the standard direct endonasal
approach is well tolerated, with relatively few long-term rhino-
logical complaints. The elimination of nasal packing is associated
with more nasal congestion and decreased airﬂow at 2 weeks after
surgery. By 3 months after surgery, 64e74% of all patients in the
cohort had no rhinological complaints and only 2% had severe
rhinological complaints. Persistent nasal congestion, either mod-
erate (15%) or severe (2%), was the most common long-term
complaint.In this study, 12 patients had preoperative headaches, 50% of
whom had complete resolution within 2 weeks after surgery.
Twenty-two patients had preoperative visual defects, although 16
(72%) of them improved. None of the 39 patients experienced
postoperative worsening of visual acuity or visual ﬁelds, or new
cranial nerve palsies.
Subgroup analysis revealed several ﬁndings. Craniotomy pa-
tients had longer hospital stays (36 days) and had higher rates of
new postoperative headaches and pneumonia (44% each). Finally,
in patients with complications in the endonasal group with long
term of hospital stay 22 days but headache and rhinological com-
plaints at 3 months, follow-up were similar to patients without
complication.
5.1. Rhinological complications and complaints
The endonasal route is perhaps most notable for its minimiza-
tion of nasal and sinus complications. There were no nasoseptal
perforations, hematomas or abscesses seen in this series. In
contrast, after sublabial transseptal transsphenoidal surgery, rhi-
nological complications have been known to range as high as
28e35%.23e25 Eisele et al,23 reported nasoseptal perforations in
1e13% of patients, upper lip paresthesia in 5e28% of patients,23 and
postoperative anosmia in 5.5% of patients.24,26 The transseptal
endonasal approach, which requires extensive anterior nasal septal
dissection, was reported by Sharma24 to have a relatively high rate
of complaints and nasal complications (21%), including septal per-
forations (7%), synechiae (12%), and a septal abscess (1%), which
were in line with Eisele.23 In another report by Spencer27 in which
the sublabial approach was compared with the trans-septal endo-
nasal approach, postoperative complaints of pain and numbness
were noted by 50 and 50% of patients, respectively, after the sub-
labial approach, and by 25 and 75% of trans-septal patients overall.
5.2. Neurosurgical morbidity rates and hormonal loss
The rates of surgical complications in this series are similar to
those reported for several recent trans-sphenoidal
series.12,23,26,28e30 Preservation of anterior pituitary functioning
was achieved in most patients, with hormonal loss occurring in
only 10% of patients. The rate of permanent DI for patients with
adenomas (2%) was similar to previous reports, in which rates
generally range from 2 to 5%.26,29,31,32
5.3. Carotid artery injury
Although they were thought to occur infrequently (<0.2% in
large series involving experienced pituitary surgeons12,33,34), the
national survey on complications of transsphenoidal surgery,
including 958 pituitary surgeons, reported an ICA injury rate of
1.1%.26 Vascular injury is a major contributor to the mortality
associated with the procedure.26 Cappabianca et al,35 reported one
ICA injury out of 233 trans-sphenoidal endoscopic procedures,
which was managed successfully by endovascular treatment. In our
study, one patient (2.5%) with a carotid artery injury was managed
by endovascular placement of Guglielmi coils and recovered
without complications.
5.4. Study limitations
There were two major limitations to this study. First, because
routine postoperative rhinological inspections were not performed,
it is possible that nasal-septal perforations, synechiae or other
sinonasal trauma were not discovered. In particular, such ﬁndings
may have been presented to those patients who complained of
C.-P. Hsu et al. / Journal of Cancer Research and Practice 3 (2016) 39e4444persistent facial pain, nasal congestion, decreased airﬂow or
decreased sense of smell.
Second, although the questionnaire items were internally
consistent and met criteria for good testing, based on the quality
control ﬁt statistics provided by the Rasch model, the questionnaire
was retrospective with respect to patient impressions, 2 weeks
after surgery. Although this raises the question of possible “soft-
ening” of one's impressions of the early postoperative surgical
experience, there was an almost unanimous decrease in the
severity of complaints from the 2-week to the 3-month time point
after surgery.
6. Conclusions
The direct endonasal transsphenoidal approach with an oper-
ating microscope is associated with a rapid rhinological recovery
and a low occurrence of serious, long-term sinonasal complaints.
Because it obviates the oral incision, extensive mucosal dissection
and nasal packing required of the sublabial transsphenoidal
approach, it appears to afford a rhinologically superior patient re-
covery with fewer sinonasal complaints and a shorter hospital stay.
However, not surprisingly, in a small minority of patients, signiﬁ-
cant discomfort persists after the direct endonasal approach.
Whether or not a purely endoscopic endonasal approach can
eliminate such complaints remains to be proven.
Conﬂict of interest
None.
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